Funded Tech Companies

Caldera Therapeutics

Headquartered in Cambridge, Caldera Therapeutics has funding from venBio, Wellington Management Company and Omega Funds.

Company Overview

Company Name
Caldera Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
300 Technology Square 8th Fl
Cambridge, MA 02139
US
Phone
Undisclosed
Email Address

Company Background Information

Overview
Caldera Therapeutics is a clinical stage company developing CLD-423, a first-in-class bispecific antibody targeting the clinically validated IL-23p19 and TL1A pathways for the treatment of inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases. Supported by leading biotech investors Atlas Venture, LAV, venBio, Omega Funds, Wellington Management and Janus Henderson Investors, Caldera has assembled a senior leadership team with deep experience in the discovery and development of IBD therapeutics and a proven track record of building biotechnology companies through to successful exits.
Profile
Caldera Therapeutics LinkedIn Company Profile
Social Media
Caldera Therapeutics Company Twitter Account
Company News
Caldera Therapeutics News
Facebook
Caldera Therapeutics on Facebook
YouTube
Caldera Therapeutics on YouTube
Last Transaction
1/14/2026

Financing History

Date
Type
Amount
Venture Equity
$112,500,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Praveen Tipirneni
  Praveen Tipirneni LinkedIn Profile  Praveen Tipirneni Twitter Account  Praveen Tipirneni News  Praveen Tipirneni on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Caldera + Lab | Calderome

 

Share this article

 


About Our Venture Capital Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary